SMICES selected by accelerator EUROBIOMED

After having applied for EUROBIOMED’s “Invest in Biomed” programme, SMICES was selected to be part of this programme of excellence specialising in health.


It is accelerating health sector development, from basic research to the market, for the benefit of patients and the economy in the South of France.

EUROBIOMED offers resources and dedicated solutions to companies and research organisations in the health sector to help them innovate, finance, develop and achieve their strategic and commercial objectives with the ultimate goal of improving the care and lives of patients.

What is the “Invest in Biomed” programme?

It is a programme of excellence aimed at innovative companies in the field of biotech and medtech in the South of France ready to raise funds to finance their development. This is a unique opportunity for SMICES to meet some twenty investment funds united to invest in our project, after we present our innovation during a 15-minute pitch followed by a Q&A session.

Invest in Biomed is an event on a human scale, which combines a high level of variety and proximity for quality exchanges with investors.

In addition, to increase our chances of attracting these investors, SMICES will benefit from personalised support from their team and experts from their network to strengthen our project and make our presentations more attractive: presentation review, pitch training, mentoring and pitches to mocks.

Every year Invest in Biomed comprises:

•  Around 20 investors
•  Around 30 start-up candidates
•  Around 10 selected companies
•  Around 10 million euros of funds to raise

Partagez cet article sur :
Catégories :

Smices Surgical